Nhrscience

Nhrscience sells condition-specific dietary supplements built around patented, clinically backed botanicals and metabolites; flagship lines include Nobiletin, Pomella® pomegranate extract, and brain-health nootropics. SKUs run from single-ingredient powders to finished capsules and stick packs; price points sit mid-range to premium, $29–$79 for 30-day supplies. The company is online-first, selling direct through nhrscience.com and Amazon, while supplying raw materials to finished-goods brands worldwide. The brand’s edge is science-forward transparency: every ingredient is trademarked, IRB-studied, and delivered at the exact human efficacious dose used in publications. QR-coded bottles link to PubMed studies, chromatograms, and GRAS safety summaries; patented extraction processes (e.g., U.S. 9,856,324 for Pomella®) create IP moats competitors cannot legally replicate. Their Pomella® 30% punicalagin extract and 40% Nobiletin complex are cited in more than 15 peer-reviewed journals, giving practitioners confidence to recommend them. Core buyers are 30-55-year-old health professionals, biohackers, and longevity-focused consumers who track biomarkers and want evidence over hype. They value clean-label, non-GMO, vegan capsules and are willing to pay for measurable outcomes—improved LDL particle size, reduced inflammatory cytokines, or enhanced working-memory scores—validated by before/after blood work or cognitive tests. Nhrscience competes in the crowded “clinical-grade nutraceutical” tier against brands that rely on generic extracts or proprietary blends without disclosed dosages. It differentiates by owning the entire supply chain from cultivar selection to finished capsule, publishing peer-reviewed data on its exact SKUs, and offering both consumer bottles and bulk powder for formulators—dual revenue streams that keep unit costs lower than single-channel premium competitors.